Tirzepatide and semaglutide are appropriate for patients who: Have at least 20 pounds of fat to lose Struggle with cravings, overeating, or stalled progress despite trying on their own Have signs of insulin resistance, metabolic syndrome, or hormone-related weight gain Want a physician-led, sustainable plan that protects metabolism, muscle, and appearance Who Should Not Use Tirzepatide (Zepbound) or Semaglutide (Wegovy)
We will collaborate with your care team
The table below depicts the timing of when many GLP1 receptor agonists became commercially available
Use to have a hard time getting the weight off but this has helped SO MUCH
Semaglutide can cause nausea, vomiting, and reduced food intake, which may affect vitamin K absorptiona factor that influences warfarin effectiveness
Other promising tools for schizophrenia If I could turn back the clock, I would have given all of these to my brother